231 related articles for article (PubMed ID: 16581748)
1. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.
Cunningham AL; Taylor R; Taylor J; Marks C; Shaw J; Mindel A
Sex Transm Infect; 2006 Apr; 82(2):164-8. PubMed ID: 16581748
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of herpes simplex virus type 1 and type 2 among the Indigenous population of Cape York, Far North Queensland, Australia.
Brazzale AG; Russell DB; Cunningham AL; Taylor J; McBride WJ
Sex Health; 2010 Dec; 7(4):453-9. PubMed ID: 21062586
[TBL] [Abstract][Full Text] [Related]
3. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.
Uusküla A; Nygard-Kibur M; Cowan FM; Mayaud P; French RS; Robinson JN; Brown DW
Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
Bradley H; Markowitz LE; Gibson T; McQuillan GM
J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
6. Upstairs and downstairs: socio-economic and gender interactions in herpes simplex virus type 2 seroprevalence in australia.
Page A; Taylor R; Richters J; Shaw J; Taylor J; Cunningham A; Mindel A
Sex Transm Dis; 2009 Jun; 36(6):344-9. PubMed ID: 19556928
[TBL] [Abstract][Full Text] [Related]
7. Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland.
Smith JS; Rosinska M; Trzcinska A; Pimenta JM; Litwinska B; Siennicka J
Sex Transm Infect; 2006 Apr; 82(2):159-63. PubMed ID: 16581747
[TBL] [Abstract][Full Text] [Related]
8. [Herpes simplex virus type 1 and 2 in Switzerland].
Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study.
Bünzli D; Wietlisbach V; Barazzoni F; Sahli R; Meylan PR
BMC Infect Dis; 2004 Mar; 4():10. PubMed ID: 15113449
[TBL] [Abstract][Full Text] [Related]
10. Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men.
Arama V; Cercel AS; Vladareanu R; Mihai C; Mihailescu R; Rankin J; Goschin S; Filipescu A; Rafila A; Arama S; Hristea A; Malkin JE; Pimenta JM; Smith JS
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e25-31. PubMed ID: 20106695
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of genital herpes simplex virus infection in developed countries.
Malkin JE
Herpes; 2004 Apr; 11 Suppl 1():2A-23A. PubMed ID: 15115626
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
Schulte JM; Bellamy AR; Hook EW; Bernstein DI; Levin MJ; Leone PA; Sokol-Anderson ML; Ewell MG; Wolff PA; Heineman TC; Belshe RB
South Med J; 2014 Feb; 107(2):79-84. PubMed ID: 24926671
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.
Shen JH; Huang KY; Chao-Yu C; Chen CJ; Lin TY; Huang YC
PLoS One; 2015; 10(8):e0134178. PubMed ID: 26252011
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya.
Mugo N; Dadabhai SS; Bunnell R; Williamson J; Bennett E; Baya I; Akinyi N; Mohamed I; Kaiser R
Sex Transm Dis; 2011 Nov; 38(11):1059-66. PubMed ID: 21992985
[TBL] [Abstract][Full Text] [Related]
15. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.
Balaeva T; Grjibovski AM; Sidorenkov O; Samodova O; Firsova N; Sannikov A; Klouman E
BMC Infect Dis; 2016 Oct; 16(1):616. PubMed ID: 27793121
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study.
Kucera P; Gerber S; Marques-Vidal P; Meylan PR
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):13-7. PubMed ID: 21982938
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for herpes simplex infection among patients at high risk for HIV infection in Brazil.
Lupi O
Int J Dermatol; 2011 Jun; 50(6):709-13. PubMed ID: 21595666
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.
Xu F; Schillinger JA; Sternberg MR; Johnson RE; Lee FK; Nahmias AJ; Markowitz LE
J Infect Dis; 2002 Apr; 185(8):1019-24. PubMed ID: 11930310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
